The study by Dinan et al.(8) has been considered instrumental in linking changes in cytokine levels with IBS symptoms, and has shown that a medicine-induced increase in the level of the pro-inflammatory cytokine IL-6 is associated with increased abdominal pain/discomfort and bloating. Here, IL6 is linked to irritable bowel syndrome.